跳至主要内容
临床试验/NCT00219869
NCT00219869Unknown4 期

Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache

Rapoport, Alan, M.D.2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2005年7月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
发起方
入组人数
30
试验地点
2
主要终点
Primary Headache Efficacy Measure; number of pain free days after 3 months

研究概览

简要总结

Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).

详细描述

Headache is the most common symptom after a closed head injury, persisting for more then 2 months in 60% of the patients. CPTH is an important cause of consultations in neurology offices and headache clinics, posing a severe burden and affecting the quality of life of sufferers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age range 18-75 CPTH according to ICHD-2 Fertile woman using adequate birth control Willing and able to give informed consent Willing and able to complete the entire course of the study to comply with study instructions Stable does of preventive medication

排除标准

  • Subject is pregnant or lactating Significant medical or psychiatric disease Previous failure to 4 or more adequate trials of preventive medication Patient on non-stable dose of medication used to prevent CPTH

结局指标

主要结局

Primary Headache Efficacy Measure; number of pain free days after 3 months

次要结局

  • Consumption of rescue medication
  • Number of days with moderate or severe headache after 3 months.

研究者

发起方
Rapoport, Alan, M.D.
申办方类型
Indiv

研究点 (2)

Loading locations...

相似试验